Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2022-03-17 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-16 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-15 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-14 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-11 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-10 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-09 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-08 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-07 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-04 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-03 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-02 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-01 $0.000001 $0.000001 $0.000001 $0.000001 500
2022-02-28 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-25 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-24 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-23 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-22 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-18 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-17 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-16 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-15 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-14 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-11 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-02-10 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT